Teladoc Health, Inc. (BVMF:T2DH34)

Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of BRL 7.02 billion. The enterprise value is 8.69 billion.

Market Cap	7.02B
Enterprise Value	8.69B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.59%
Shares Change (QoQ)	+0.58%
Owned by Insiders (%)	1.10%
Owned by Institutions (%)	74.51%
Float	175.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.95
P/TBV Ratio	n/a
P/FCF Ratio	4.70
P/OCF Ratio	4.50
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 59.09, with an EV/FCF ratio of 5.82.

EV / Earnings	-7.30
EV / Sales	0.65
EV / EBITDA	59.09
EV / EBIT	n/a
EV / FCF	5.82

Financial Position

The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.75.

Current Ratio	2.70
Quick Ratio	2.33
Debt / Equity	0.75
Debt / EBITDA	37.51
Debt / FCF	3.72
Interest Coverage	-8.26

Financial Efficiency

Return on equity (ROE) is -15.42% and return on invested capital (ROIC) is -4.04%.

Return on Equity (ROE)	-15.42%
Return on Assets (ROA)	-3.48%
Return on Invested Capital (ROIC)	-4.04%
Return on Capital Employed (ROCE)	-7.22%
Revenue Per Employee	2.66M
Profits Per Employee	-235,492
Employee Count	5,500
Asset Turnover	0.79
Inventory Turnover	19.86

Taxes

Income Tax	-141.20M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.53% in the last 52 weeks. The beta is 2.04, so Teladoc Health's price volatility has been higher than the market average.

Beta (5Y)	2.04
52-Week Price Change	-30.53%
50-Day Moving Average	1.48
200-Day Moving Average	1.55
Relative Strength Index (RSI)	39.47
Average Volume (20 Days)	45,954

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.29

Income Statement

In the last 12 months, Teladoc Health had revenue of BRL 13.47 billion and -1.19 billion in losses. Loss per share was -6.81.

Revenue	13.47B
Gross Profit	9.40B
Operating Income	-951.76M
Pretax Income	-1.33B
Net Income	-1.19B
EBITDA	86.18M
EBIT	-951.76M
Loss Per Share	-6.81

Balance Sheet

The company has 3.87 billion in cash and 5.55 billion in debt, giving a net cash position of -1.68 billion.

Cash & Cash Equivalents	3.87B
Total Debt	5.55B
Net Cash	-1.68B
Net Cash Per Share	n/a
Equity (Book Value)	7.42B
Book Value Per Share	41.83
Working Capital	3.66B

Cash Flow

In the last 12 months, operating cash flow was 1.56 billion and capital expenditures -66.12 million, giving a free cash flow of 1.49 billion.

Operating Cash Flow	1.56B
Capital Expenditures	-66.12M
Free Cash Flow	1.49B
FCF Per Share	n/a

Margins

Gross margin is 69.80%, with operating and profit margins of -7.06% and -8.84%.

Gross Margin	69.80%
Operating Margin	-7.06%
Pretax Margin	-9.89%
Profit Margin	-8.84%
EBITDA Margin	0.64%
EBIT Margin	-7.06%
FCF Margin	11.08%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.59%
Shareholder Yield	-3.59%
Earnings Yield	-16.97%
FCF Yield	21.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -6.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.41
Piotroski F-Score	4